Thank you MOOMOOOOOO…. Christmas gift received in good condition and it’s very classy and nice!
2
$ChemoCentryx (CCXI.US)$
ChemoCentryx, Inc.'s (NASDAQ:CCXI) avacopan was the only new molecular entity approved during the month. NMEs are new drug products containing an active ingredient that is marketed for the first time in the U.S. Avacopan, which is to go by the brand name Tavneos, has been approved for treating small blood vessel damage.
It’s all good. let’s go!
ChemoCentryx, Inc.'s (NASDAQ:CCXI) avacopan was the only new molecular entity approved during the month. NMEs are new drug products containing an active ingredient that is marketed for the first time in the U.S. Avacopan, which is to go by the brand name Tavneos, has been approved for treating small blood vessel damage.
It’s all good. let’s go!
8
$Arcturus Therapeutics (ARCT.US)$- do your DD- on all positive news from here!
“The most important thing here is that WHO chose ARCT for one of the 4 vaccine candidates and sponsor and fund phase 3 for arct021.
ARCT has very good mRNA platforms, and hence very valuable IPs. Arct021 was the original vaccine candidate to tackle covid19. With the emergence of variants, ARCT has quickly updated and came up with arct154 and arct165. If ARCT can get EUA in Vietnam for arct154, the potential would be immense. Arct021 is a one dose vaccine and that has a lot of advantages. Despite the fact that many may already have been vaccinated, but arct021 can still be effective as a one dose vaccine since from research reports, neutralising antibodies dropped to very low levels after 6 months with the other vaccines. So, arct021, arct154 and arct165 still have very good potentials in the vaccine market and can also be as booster shots.
In the future, if we have another outbreak of diseases, ARCT can be the go-to company to quickly develop a vaccine besides BionTech and Moderna. The mRNA platforms of ARCT, in my opinion, is better than its competitors. Some big pharmas are behind the curve in mRNA technology and they may look to acquire ARCT. The only weakness for ARCT was that it was a standalone biotech and there was no support or tie-up with another big pharma during the covid crisis as compared to BionTech with Pfizer, and Moderna getting lots of funding etc....” qoutes from (Seeking Alpha- comments)
“The most important thing here is that WHO chose ARCT for one of the 4 vaccine candidates and sponsor and fund phase 3 for arct021.
ARCT has very good mRNA platforms, and hence very valuable IPs. Arct021 was the original vaccine candidate to tackle covid19. With the emergence of variants, ARCT has quickly updated and came up with arct154 and arct165. If ARCT can get EUA in Vietnam for arct154, the potential would be immense. Arct021 is a one dose vaccine and that has a lot of advantages. Despite the fact that many may already have been vaccinated, but arct021 can still be effective as a one dose vaccine since from research reports, neutralising antibodies dropped to very low levels after 6 months with the other vaccines. So, arct021, arct154 and arct165 still have very good potentials in the vaccine market and can also be as booster shots.
In the future, if we have another outbreak of diseases, ARCT can be the go-to company to quickly develop a vaccine besides BionTech and Moderna. The mRNA platforms of ARCT, in my opinion, is better than its competitors. Some big pharmas are behind the curve in mRNA technology and they may look to acquire ARCT. The only weakness for ARCT was that it was a standalone biotech and there was no support or tie-up with another big pharma during the covid crisis as compared to BionTech with Pfizer, and Moderna getting lots of funding etc....” qoutes from (Seeking Alpha- comments)
6
2
My super layman way of describing buying in stocks-
- when I am younger(no commitments but with potential) buying stocks is like finding girlfriends/ boyfriends. I have time but limited capital in my hands- up my ante and take the risks! Ride the waves but learn from mistakes. I win some, lose some too!
- when I aged (with commitment but no less potential🤣) buying stocks is like finding potential partner- knowing which stocks you wanted to buy in(with research and charts) and how much you are willing to invest/ confident in the company for future even when market is down. Stability and security (FAANMG)
On the part about stocks selling-
- Everyone seems to have a target price of what they wanted or when to sell. I have yet to master the selling part as I an aiming to stay on this long term relationship with these companies. I am too vested or maybe 🤔 too comfortable in not taking any more risks??!! Maybe it’s like old married couple!!
Teach me when to let go! 🤣🤣 I am still learning.…😊
- when I am younger(no commitments but with potential) buying stocks is like finding girlfriends/ boyfriends. I have time but limited capital in my hands- up my ante and take the risks! Ride the waves but learn from mistakes. I win some, lose some too!
- when I aged (with commitment but no less potential🤣) buying stocks is like finding potential partner- knowing which stocks you wanted to buy in(with research and charts) and how much you are willing to invest/ confident in the company for future even when market is down. Stability and security (FAANMG)
On the part about stocks selling-
- Everyone seems to have a target price of what they wanted or when to sell. I have yet to master the selling part as I an aiming to stay on this long term relationship with these companies. I am too vested or maybe 🤔 too comfortable in not taking any more risks??!! Maybe it’s like old married couple!!
Teach me when to let go! 🤣🤣 I am still learning.…😊
1
2
AstroGal OP : Ohhh.. wOw!! I didn’t see them in separate reward redemption, but thanks for the information, I will make sure I check out everything before using my points next time!